Paper32377286
Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.
Papetti L and 9 others. Pain Res Manag, 2020. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study. Papers, record 32377286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32377286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot Study.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics | Major topic |
| Ethanolamines | Major topic |
| Migraine Disorders | Major topic |
| Palmitic Acids | Major topic |
| Amides | |
| Child | |
| Female | |
| Humans | |
| Male | |
| Pilot Projects | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06562400 | Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments | Background |
Source ClinicalTrials.gov
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8931279 | Nerve growth factor: from neurotrophin to neurokine. | Trends Neurosci | 1996 | https://conductscience.org/library/papers/8931279 | PubMed |
| 2 | 19926854 | Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19926854 | PubMed |
| 3 | 18984840 | High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. | J Child Neurol | 2008 | https://conductscience.org/library/papers/18984840 | PubMed |
| 4 | 17876302 | The orphan receptor GPR55 is a novel cannabinoid receptor. | Br J Pharmacol | 2007 | https://conductscience.org/library/papers/17876302 | PubMed |
| 5 | 30706796 | Short-Term Ultramicronized Palmitoylethanolamide Therapy in Patients with Myasthenia Gravis: a Pilot Study to Possible Future Implications of Treatment. | CNS Neurol Disord Drug Targets | 2019 | https://conductscience.org/library/papers/30706796 | PubMed |
| 6 | 15465922 | The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Mol Pharmacol | 2005 | https://conductscience.org/library/papers/15465922 | PubMed |
| 7 | 27017022 | Complementary and Integrative Approaches for Pediatric Headache. | Semin Pediatr Neurol | 2016 | https://conductscience.org/library/papers/27017022 | PubMed |
| 8 | 30038237 | Paediatric migraine: evidence-based management and future directions. | Nat Rev Neurol | 2018 | https://conductscience.org/library/papers/30038237 | PubMed |
| 9 | 1771000 | Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. | Neuroscience | 1991 | https://conductscience.org/library/papers/1771000 | PubMed |
| 10 | 11485574 | Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. | Biochem J | 2001 | https://conductscience.org/library/papers/11485574 | PubMed |
| 11 | 21521206 | Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). | Headache | 2011 | https://conductscience.org/library/papers/21521206 | PubMed |
| 12 | 29368949 | Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. | Cephalalgia | 2018 | https://conductscience.org/library/papers/29368949 | PubMed |
| 13 | 19625089 | Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. | Vet Immunol Immunopathol | 2010 | https://conductscience.org/library/papers/19625089 | PubMed |
| 14 | 902351 | [Impulsin in the prevention of acute respiratory diseases in school children]. | Cesk Pediatr | 1977 | https://conductscience.org/library/papers/902351 | PubMed |
| 15 | 30827269 | Ultramicronized Palmitoylethanolamide (um-PEA) as Add-on Treatment in Fibromyalgia Syndrome (FMS): Retrospective Observational Study on 407 Patients. | CNS Neurol Disord Drug Targets | 2019 | https://conductscience.org/library/papers/30827269 | PubMed |
| 16 | 24443395 | Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations. | Cephalalgia | 2014 | https://conductscience.org/library/papers/24443395 | PubMed |
| 17 | 20166923 | Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. | Curr Med Chem | 2010 | https://conductscience.org/library/papers/20166923 | PubMed |
| 18 | 27788026 | Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. | N Engl J Med | 2017 | https://conductscience.org/library/papers/27788026 | PubMed |
| 19 | 28727699 | Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. | Pain Physician | 2017 | https://conductscience.org/library/papers/28727699 | PubMed |
| 20 | 23109652 | Migraine and migraine subtypes in preadolescent children: association with school performance. | Neurology | 2012 | https://conductscience.org/library/papers/23109652 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42812398 | ALIAmides and pediatric health: a structured narrative review. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42812398 | PubMed |
| 41745090 | Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory Shield. | Diseases | 2026 | https://conductscience.org/library/papers/41745090 | PubMed |
| 40630421 | Treatment of Migraine With Phytocannabinoids, the Involvement of Endocannabinoids in Migraine, and Potential Mechanisms of Action. | Pain Res Manag | 2025 | https://conductscience.org/library/papers/40630421 | PubMed |
| 40563990 | Palmitoylethanolamide: A Multifunctional Molecule for Neuroprotection, Chronic Pain, and Immune Modulation. | Biomedicines | 2025 | https://conductscience.org/library/papers/40563990 | PubMed |
| 40276532 | Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial. | Front Nutr | 2025 | https://conductscience.org/library/papers/40276532 | PubMed |
| 39941827 | The Challenge of Managing Neuropathic Pain in Children and Adolescents with Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941827 | PubMed |
| 39482575 | Hallmarks of primary headache: part 1 - migraine. | J Headache Pain | 2024 | https://conductscience.org/library/papers/39482575 | PubMed |
| 39433509 | Palmitoylethanolamide, an endogenous fatty acid amide, and its pleiotropic health benefits: A narrative review. | J Biomed Res | 2024 | https://conductscience.org/library/papers/39433509 | PubMed |
| 38592096 | Non-Pharmacological Treatments in Paediatric Migraine. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592096 | PubMed |
| 38399360 | Effectiveness of Palmitoylethanolamide (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38399360 | PubMed |
| 36443965 | Ultramicronized N-palmitoylethanolamine Contributes to Morphine Efficacy Against Neuropathic Pain: Implication of Mast Cells and Glia. | Curr Neuropharmacol | 2024 | https://conductscience.org/library/papers/36443965 | PubMed |
| 36361803 | Salivary Endocannabinoid Profiles in Chronic Orofacial Pain and Headache Disorders: An Observational Study Using a Novel Tool for Diagnosis and Management. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361803 | PubMed |
| 36175833 | Alterations in metabolic flux in migraine and the translational relevance. | J Headache Pain | 2022 | https://conductscience.org/library/papers/36175833 | PubMed |
| 35911893 | From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years? | Front Neurol | 2022 | https://conductscience.org/library/papers/35911893 | PubMed |
| 34444875 | Truths and Myths in Pediatric Migraine and Nutrition. | Nutrients | 2021 | https://conductscience.org/library/papers/34444875 | PubMed |
| 34069940 | Palmitoylethanolamide: A Natural Compound for Health Management. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34069940 | PubMed |
| 34062792 | The Role of Metabolism in Migraine Pathophysiology and Susceptibility. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34062792 | PubMed |
| 33805489 | Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide? | Animals (Basel) | 2021 | https://conductscience.org/library/papers/33805489 | PubMed |
| 33333772 | Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33333772 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CALCA | 796 | PubTator's text mining | https://conductscience.org/library/genes/796 | NCBI Gene |
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 | NCBI Gene |
| CNR2 | 1269 | PubTator's text mining | https://conductscience.org/library/genes/1269 | NCBI Gene |
| F5 | 2153 | PubTator's text mining | https://conductscience.org/library/genes/2153 | NCBI Gene |
| FAAH | 2166 | PubTator's text mining | https://conductscience.org/library/genes/2166 | NCBI Gene |
| GPR55 | 9290 | PubTator's text mining | https://conductscience.org/library/genes/9290 | NCBI Gene |
| PPARA | 5465 | PubTator's text mining | https://conductscience.org/library/genes/5465 | NCBI Gene |
| TRPV1 | 7442 | PubTator's text mining | https://conductscience.org/library/genes/7442 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32377286
GET https://conductscience.org/api/papers/v1/32377286/references?page=2